These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7981959)

  • 41. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of syndromes of insulin resistance with coronary artery disease.
    LeWinter MM
    Coron Artery Dis; 2005 Dec; 16(8):477-80. PubMed ID: 16319657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
    Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV
    Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
    Rosenberg DE; Jabbour SA; Goldstein BJ
    Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice.
    Ranheim T; Dumke C; Schueler KL; Cartee GD; Attie AD
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3286-93. PubMed ID: 9409324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease.
    Fonseca VA
    Am J Cardiol; 2003 Aug; 92(4A):50J-60J. PubMed ID: 12957327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk?
    Lemieux I
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):795-7. PubMed ID: 15132969
    [No Abstract]   [Full Text] [Related]  

  • 49. Epidemiology of insulin resistance and its relation to coronary artery disease.
    Haffner SM
    Am J Cardiol; 1999 Jul; 84(1A):11J-14J. PubMed ID: 10418852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Born small for gestational age: increased risk of type 2 diabetes, hypertension and hyperlipidaemia in adulthood.
    Jaquet D; Czernichow P
    Horm Res; 2003; 59 Suppl 1():131-7. PubMed ID: 12638526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].
    Valensi P
    Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study.
    Gray RS; Fabsitz RR; Cowan LD; Lee ET; Howard BV; Savage PJ
    Am J Epidemiol; 1998 Nov; 148(9):869-78. PubMed ID: 9801017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
    Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
    Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Non-pharmacological therapy of metabolic syndrome].
    Wirth A
    Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-resistance syndrome and cardiovascular complications of non-insulin-dependent diabetes mellitus.
    Fontbonne A
    Diabetes Metab; 1996 Oct; 22(5):305-13. PubMed ID: 8896991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preventing heart failure in patients with diabetes.
    Srikanthan P; Hsueh W
    Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The metabolic syndrome. Part II: its mechanisms of development and its complications].
    Pacholczyk M; Ferenc T; Kowalski J
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():543-58. PubMed ID: 18936730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.